Table 3.
Day | 6MS | 1MS/6MN-S | 1MN-S | P -value |
---|---|---|---|---|
Day 1 |
0.27 (0.11-0.76)* |
0.46 (0.13-0.50)† |
0.10 (0.05-0.26) |
<0.001 |
(n = 109) |
(n = 21) |
(n = 68) |
|
|
Day 4 |
0.29 (0.13-0.92)* |
0.25 (0.09-0.71)† |
0.07 (0.05-0.24) |
<0.001 |
(n = 109) |
(n = 21) |
(n = 50) |
|
|
Day 8 | 0.59 (0.13-1.00)* |
0.15 (0.08-0.68) |
0.06 (0.04-0.25) |
<0.001 |
(n = 109) | (n = 21) | (n = 37) |
*P-values <0.001 for the comparison between patients who were 6-month survivors (6MS) and 1-month non-survivors (1MN-S); †P-values <0.05 for the comparison between patients who were 1-month but non-6-month survivors (1MS/6MN-S) and 1MN-S. The remainder of the paired comparisons were not statistically significant.